Alto, Cencora team up to optimize patient experience for specialty medications

The collaboration aims to accelerate patient access to prescribed specialty medications.

3/19/2025

Alto and Cencora are collaborating to deliver enhanced patient support services and streamline access to prescribed specialty medications. The collaboration leverages Cencora’s patient support services and expertise and Alto’s tailored technology solutions.

“Alto helps our partners elevate the patient experience, improve medication access and set new standards for convenience, cost and care,” said Alicia Boler Davis, CEO at Alto. “Cencora is a pioneer in the healthcare industry, and we are thrilled to work with their team to drive innovation and create a better pharmacy experience, together.”

Cencora partners with pharmaceutical companies to deliver integrated patient support – including comprehensive access, affordability and adherence support aimed at reducing potential barriers to access and improving speed-to-therapy. Cencora uses automation and emerging technologies to expedite processes across the entire patient journey, from intake and benefit verification through to fulfillment.

[Watch DSN: Cencora, Good Neighbor Pharmacy look to pharmacists to fill in care gaps]

Alto uses automation, machine learning and data-driven insights to enhance patient support services by driving efficiencies, delivering personalized patient engagement and helping improve patient adherence and the patient experience. In this collaboration with Cencora, Alto further accelerates patient access by digitizing and optimizing the intake and billing process, enabling prescriptions to be processed and transferred to dispensing pharmacies more efficiently, with less cost.

“As our pharmaceutical partners and the patients they serve navigate a complex and evolving healthcare system, we continue to invest in solutions and create strategic relationships to deliver best-in-class support that helps patients start and stay on prescribed therapies,” said Guy Payette, president of Innomar Strategies and Biopharma Services North America, Cencora. “This collaboration with Alto reflects our commitment to build solutions that address unmet market needs and elevate the patient experience.”